Is There An Opportunity With ProQR Therapeutics N.V.'s (NASDAQ:PRQR) 37% Undervaluation?

Yahoo FinanceDec 20 07:19 ET

ProQR Therapeutics N.V. (NASDAQ:PRQR) Shares May Have Slumped 29% But Getting In Cheap Is Still Unlikely

Simply Wall StDec 14 07:31 ET

Chardan Capital Maintains ProQR Therapeutics(PRQR.US) With Buy Rating, Maintains Target Price $4

Moomoo NewsDec 12 08:31 ET · Ratings

ProQR Therapeutics Expands Collaboration With RSRT With $8.1 Mln Funding For AX-2402

RTTNewsDec 12 08:11 ET

ProQR Therapeutics Is Maintained at Buy by Chardan Capital

Dow JonesDec 12 07:59 ET · Ratings

H.C. Wainwright Maintains ProQR Therapeutics(PRQR.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsDec 12 07:31 ET · Ratings